查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1947444

血浆疗法市场：依类型、应用、最终用户和地区划分 - 全球预测（～2036年）

Plasma Therapy Market by Type, Application, End User, and Geography - Global Forecast to 2036
出版日期: | 出版商: Meticulous Research | 英文 175 Pages | 商品交期: 5-7个工作天内

价格
简介目录

全球血浆疗法市场在预测期（2026-2036年）预计将以 10.4%的年复合成长率成长，从2026年的8.2亿美元成长到2036年的约 22.1亿美元。本报告对五大主要地区的血浆疗法市场进行了详细分析，重点关注当前市场趋势、市场规模、近期发展以及至2036年的预测。透过广泛的二级和一级研究以及对市场现状的详细分析，对关键产业驱动因素、限制因素、机会和挑战进行了影响分析。

推动血浆疗法市场成长的关键因素包括：富血小板血浆（PRP）疗法已确立的治疗益处、医疗保健专业人员和患者对 PRP 疗法的认知度不断提高、肌肉骨骼和运动损伤的增加以及全球美容手术数量的成长。此外，PRP疗法在各个医学专科领域的应用不断扩展、PRP製备系统的技术进步以及新兴经济体医疗基础设施的发展，预计将为血浆疗法市场的企业创造巨大的成长机会。

主要市场趋势

PRP应用扩展到骨科以外：推动血浆疗法市场发展的一个关键趋势是PRP的应用范围已从传统的骨科和运动医学扩展到各个医学专科。皮肤科和美容医学已成为重要的成长领域，PRP用于毛髮再生、皮肤再生和抗衰老治疗。此外，PRP在临床应用范围也稳定扩大，包括风湿病学中的关节疾病管理、眼科学中的干眼症和角膜疾病，以及口腔医学和口腔外科中的口腔疾病。这些多样化的应用显着扩大目标市场，并吸引新的患者群体接受PRP疗法。

推进 PRP 製备技术及标准化：另一个主要趋势是 PRP 製备技术的进步和标准化过程。製造商开发更有效率、更便利的离心系统，以生产血小板浓度和生长因子光谱均达到最佳状态的、高品质的PRP。标准化工作目的是解决 PR 製备过程中长期存在的差异性问题，这一问题曾阻碍临床疗效和监管审批。改良的製备技术提升 PRP 治疗的临床疗效，并促进其在各种临床环境中的广泛应用。先进的自动化系统缩短製备时间并提高可重复性。

不断成长的临床证据和监管支持：越来越多的临床证据支持 PRP 在多个治疗领域的疗效，推动市场扩张。监管机构日益认可 PRP 的治疗价值，鼓励其进入市场并应用于临床。这种监管的明确性为 PRP 技术开发和临床研究的投资提供了支持。

市场区隔

依类型

依类型划分，预计到2026年，纯血小板富集血浆（PRP）将占据全球血浆疗法市场最大的占有率。纯 PRP 具有多项关键优势，包括使用风险极低、经广泛研究证实的临床疗效，以及促进组织、肌腱和骨骼癒合的成熟能力，巩固了其作为全球医疗机构中最广泛采用的PRP 製剂的地位。丰富的临床证据支持其疗效，製备过程简便，且治疗效果稳定，使其成为寻求再生医学解决方案的医疗服务提供者和患者的首选。其在各种临床应用中的多功能性和良好的安全性将继续推动市场需求的持续成长。

然而，预计在预测期内，富含白血球的PRP（L-PRP）的年复合成长率将最高。L-PRP在膝关节和髋关节骨关节炎患者中的临床应用日益广泛，加之其在某些治疗应用中展现出的良好临床效果，正推动着这一细分市场的成长。 L-PRP增强的抗发炎和免疫调节特性使其在治疗慢性发炎和退化性关节疾病方面特别有效。人们对L-PRP在某些临床情况下卓越疗效的认识不断提高，也促进了其广泛应用和市场渗透。此外，富血小板纤维蛋白（PRF）和白血球-富血小板纤维蛋白（L-PRF）作为新兴细分市场，在口腔外科、牙周治疗和先进的再生医学手术等领域具有特殊的应用前景。

依应用领域划分

预计到2026年，骨科和创伤科将占据全球血浆疗法市场最大的占有率。该领域的领先地位源于富血小板血浆（PRP）在治疗各种骨科疾病（包括肌腱损伤、韧带损伤、软骨退化和骨关节炎）方面成熟且广泛的应用记录。强而有力的临床证据支持PRP在骨科领域的疗效，骨科损伤和年龄相关退化性疾病的高发病率，以及人们对微创治疗方案日益成长的偏好，都使骨科成为主要的市场区隔。运动医学专家和骨科医生积极采用PRP疗法，将其作为治疗急性损伤和慢性退化性疾病的有效选择。

然而，预计在预测期内，皮肤科和美容领域的年复合成长率将最高。皮肤和毛髮相关疾病患者数量的增加、大众美学意识的提高以及微针和富血小板血浆（PRP）联合疗法在美容领域的日益普及，推动该行业的快速成长。 PRP在毛髮再生、皮肤再生、抗衰老治疗和痤疮疤痕修復等方面的应用，显着扩大了潜在市场。不断成长的医美市场和非手术美容疗法的普及，为基于PRP的皮肤病治疗创造了巨大的机会。此外，PRP在风湿病（用于关节疾病管理）、眼科（用于干眼症和角膜疾病）以及口腔医学（用于牙科和口腔外科手术）等领域的应用，也正获得越来越多的临床认可和应用。

依最终使用者划分

预计到2026年，医院和诊所将占据全球血浆疗法市场最大的占有率。这一领域的领先地位归因于医疗保健支出的成长、医疗专业人员对PRP疗法的认识和处方量的增加，以及这些机构拥有先进的医疗基础设施和专用设备。医院和诊所是各医疗专科 PRP 疗法的主要服务中心，为患者提供经验丰富的医生和全面的治疗方案。 PRP 疗法已融入骨科、皮肤科和其他专科的标准临床实践，推动了其持续成长的需求。

儘管目前研究机构的市场占有率较小，但它们在推进 PRP 的科学研究和临床应用方面发挥着越来越重要的作用。学术和研究机构进行先进的研发活动，以最佳化 PRP 製备技术、探索新的治疗应用并建立实证临床方案。这些研究有助于 PRP 疗法的更广泛应用和标准化，最终促进市场扩张并提高临床可靠性。

区域分析

对该行业的详细区域分析提供了对五大主要区域（北美、欧洲、亚太、拉丁美洲以及中东和非洲）及其主要国家/地区情况的详细定性和定量见解。预计到2026年，北美将引领全球血浆疗法市场，占据最大的市场占有率。这一优势主要归功于该地区完善的医疗保健基础设施、先进医疗技术的广泛应用、对再生医学的强有力的监管支持以及可观的医疗保健支出。美国是最大的市场，这得益于许多大型再生医学公司的存在、广泛的临床研发活动以及患者对富血小板血浆（PRP）疗法的高度认知和接受度。北美医疗保健专业人员积极地将PRP作为多个专科的标准治疗方案。

欧洲是第二大血浆疗法市场，这得益于其健全的医疗保健体系、再生医学方法的日益普及以及越来越多的临床证据支持PRP的有效性。德国、法国和英国等国家在引进和规范PRP疗法方面处于领先地位。该地区对实证医学和监管合规的重视，促进了市场成长和临床信誉。

预计亚太地区将在预测期内实现最快的成长。医疗基础设施的改善、医疗旅游的兴起、医疗支出的增加以及医护人员和患者对富血小板血浆（PRP）疗法的认知度不断提高，共同推动了这一加速成长。中国、印度、日本和韩国等国的血浆疗法市场正经历快速扩张。医疗体系的完善、可支配收入的增加以及体育运动参与度的提高，都显着推动了对再生医学解决方案的需求。拉丁美洲以及中东和非洲地区由于医疗投资的增加和先进疗法的日益普及，也展现出新的发展机会。

目录

第1章 引言

第2章 研究方法

第3章 执行摘要

第4章 市场洞察

  • 驱动因素
    • PRP疗法的益处
    • PRP疗法认知度的提高
    • 肌肉骨骼和运动伤害的增加趋势
    • 全球美容手术数量的增加
  • 限制因素
    • PRP疗法的替代方案
    • PRP使用的副作用
  • 机会
    • PRP的拓展应用治疗
    • 新兴经济体的医疗进展
  • 挑战
    • PRP 使用的严格监管框架
  • 波特五力分析

第5章 PRP 的适用标准

第6章 血浆疗法市场趋势

第7章 富血小板血浆疗法市场：依类型

  • 纯富血小板血浆
  • 富白血球 PRP
  • 纯富血小板纤维蛋白
  • 富白血球和血小板纤维蛋白（L-PRF）

第8章 富血小板血浆疗法市场：依应用

  • 骨科和创伤科
  • 风湿病科
  • 皮肤科和整形外科
  • 眼科
  • 口腔外科和牙科
  • 其他应用

第9章 富血小板血浆疗法市场：依最终用户

  • 医院和诊所
  • 研究机构

第10章 富血小板血浆疗法市场：依地区

  • 北美
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 其他地区欧洲
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 亚太其他地区
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 拉丁美洲其他地区
  • 中东和非洲

第11章 竞争格局

  • 关键成长策略
  • 市场占有率分析
  • 主要公司SWOT分析
  • 资金和资助评估

第12章 公司简介

  • Arthrex, Inc.
  • DePuy Synthes Inc.
  • Stryker Corporation
  • Zimmer Biomet Holdings, Inc.
  • Terumo Corporation
  • Regen Lab SA
  • EmCyte Corporation
  • Exactech Inc.
  • Global Stem Cells Group, Inc.
  • Celling Biosciences, Inc.
  • Dr PRP USA LLC
  • Juventix Regenerative Medical LLC
  • 其他

第13章 附录

简介目录
Product Code: MRHC - 104530

Plasma Therapy Market by Type (Pure Platelet-rich Plasma, Platelet-rich Fibrin), Application (Orthopedics, Dermatology, Cosmetology, Rheumatology, Ophthalmology), End User (Hospitals and Clinics, Research Institutes), and Geography - Global Forecast to 2036

According to the research report titled, 'Plasma Therapy Market by Type (Pure Platelet-rich Plasma, Platelet-rich Fibrin), Application (Orthopedics, Dermatology, Cosmetology, Rheumatology, Ophthalmology), End User (Hospitals and Clinics, Research Institutes), and Geography - Global Forecast to 2036,' the global plasma therapy market is expected to reach approximately USD 2.21 billion by 2036 from USD 0.82 billion in 2026, at a CAGR of 10.4% during the forecast period (2026-2036). The report provides an in-depth analysis of the global plasma therapy market across five major regions, emphasizing the current market trends, market sizes, recent developments, and forecasts till 2036. Following extensive secondary and primary research and an in-depth analysis of the market scenario, the report conducts the impact analysis of the key industry drivers, restraints, opportunities, and challenges.

The major factors driving the growth of the plasma therapy market include the well-documented therapeutic advantages of platelet-rich plasma (PRP) treatment, increasing awareness toward PRP therapies among healthcare professionals and patients, the rising prevalence of musculoskeletal and sports injuries, and the growing number of cosmetic procedures worldwide. Additionally, the expanding applications of PRP treatments in various medical specialties, technological advancements in PRP preparation systems, and advancing healthcare infrastructure in emerging economies are expected to create significant growth opportunities for players operating in the plasma therapy market.

Key Market Trends

Expansion of PRP Applications Beyond Orthopedics: A significant trend shaping the plasma therapy market is the expansion of PRP applications beyond traditional orthopedic and sports medicine uses into diverse medical specialties. Dermatology and cosmetology have emerged as major growth areas, with PRP being utilized for hair restoration, skin rejuvenation, and anti-aging treatments. Additionally, PRP applications in rheumatology for joint disease management, ophthalmology for dry eye syndrome and corneal disorders, and stomatology for dental and oral surgical procedures are gaining increasing clinical traction. This diversification of applications is expanding the addressable market significantly and attracting new patient populations to PRP therapy.

Technological Advancements in PRP Preparation and Standardization: Another major trend is the advancement of PRP preparation technologies and efforts toward standardization of PRP formulations. Manufacturers are developing more efficient and user-friendly centrifugation systems that produce consistent, high-quality PRP with optimal platelet concentrations and growth factor profiles. Standardization efforts are addressing the historical challenge of variability in PRP preparation, which has hindered clinical outcomes and regulatory acceptance. Improved preparation techniques are enhancing the clinical efficacy of PRP treatments and facilitating broader adoption across diverse healthcare settings. Advanced automated systems are reducing preparation time and improving reproducibility.

Increasing Clinical Evidence and Regulatory Support: Growing clinical evidence supporting PRP efficacy across multiple therapeutic applications is driving market expansion. Regulatory bodies are increasingly recognizing the therapeutic value of PRP, facilitating market entry and clinical adoption. This regulatory clarity is supporting investment in PRP technology development and clinical research.

Market Segmentation

Based on Type

By type, pure platelet-rich plasma (PRP) is expected to account for the largest share of the global plasma therapy market in 2026. Pure PRP offers several significant advantages that have established it as the most widely adopted PRP formulation across healthcare settings globally. These advantages include minimal risks associated with its use, well-established clinical efficacy supported by extensive research, and its proven ability to accelerate the healing process of tissues, tendons, and bones. The extensive body of clinical evidence supporting pure PRP efficacy, combined with its straightforward preparation process and consistent therapeutic outcomes, have made it the preferred choice for healthcare providers and patients seeking regenerative medicine solutions. Pure PRP's versatility across multiple clinical applications and its favorable safety profile continue to drive sustained market demand.

However, leukocyte-rich PRP (L-PRP) is projected to grow at the fastest CAGR during the forecast period. The increasing clinical adoption of L-PRP in patients suffering from osteoarthritis of the knee and hip joints, combined with positive clinical outcomes in specific therapeutic applications, is driving accelerated growth in this segment. L-PRP's enhanced anti-inflammatory and immunomodulatory properties make it particularly valuable for managing chronic inflammatory conditions and degenerative joint diseases. The growing recognition of L-PRP's superior therapeutic benefits in specific clinical scenarios is contributing to its expanding adoption and market penetration. Additionally, platelet-rich fibrin (PRF) and leukocyte and platelet-rich fibrin (L-PRF) represent emerging segments with specialized applications in oral surgery, periodontal treatment, and advanced regenerative procedures.

Based on Application

By application, orthopedics and traumatology is expected to account for the largest share of the global plasma therapy market in 2026. This segment's dominance is attributed to the well-established and extensively validated use of PRP in treating various orthopedic conditions, including tendon injuries, ligament damage, cartilage degeneration, and osteoarthritis. The strong clinical evidence supporting PRP efficacy in orthopedic applications, the high prevalence of orthopedic injuries and age-related degenerative conditions, and the growing preference for minimally invasive treatment alternatives have established orthopedics as the primary market segment. Sports medicine professionals and orthopedic surgeons have embraced PRP therapy as a valuable therapeutic option for managing acute injuries and chronic degenerative conditions.

The dermatology and cosmetology segment, however, is projected to grow at the fastest CAGR during the forecast period. The rising number of patients with skin and hair-related conditions, growing beauty consciousness among the general population, and increasing adoption of microneedling combined with PRP for cosmetic purposes are driving rapid growth in this segment. PRP applications for hair restoration, skin rejuvenation, anti-aging treatments, and acne scar revision are expanding the addressable market significantly. The expanding aesthetic medicine market and the popularity of non-surgical cosmetic procedures are creating substantial opportunities for PRP-based dermatological treatments. Additionally, PRP applications in rheumatology for joint disease management, ophthalmology for dry eye syndrome and corneal disorders, and stomatology for dental and oral surgical procedures are gaining increasing clinical recognition and adoption.

Based on End User

By end user, hospitals and clinics are expected to account for the largest share of the global plasma therapy market in 2026. This segment's dominance is attributed to increased healthcare spending, growing awareness and prescriptions for PRP treatments among healthcare professionals, and the availability of advanced medical infrastructure and specialized equipment in these settings. Hospitals and clinics serve as primary delivery points for PRP therapies across various medical specialties, offering patients access to experienced practitioners and comprehensive treatment protocols. The integration of PRP therapy into standard clinical practice across orthopedic, dermatological, and other specialty departments is driving sustained demand.

Research institutes, while representing a smaller market segment currently, are playing an increasingly important role in advancing PRP science and clinical applications. Academic and research institutions are conducting advanced research and development activities to optimize PRP preparation techniques, explore new therapeutic applications, and establish evidence-based clinical protocols. This research is contributing to the broader adoption and standardization of PRP therapies, ultimately supporting market expansion and clinical credibility.

Geographic Analysis

An in-depth geographic analysis of the industry provides detailed qualitative and quantitative insights into the five major regions (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) and the coverage of major countries in each region. In 2026, North America is expected to dominate the global plasma therapy market with the largest market share. This dominance is primarily attributed to the well-established healthcare infrastructure, high adoption of advanced medical technologies, strong regulatory support for regenerative medicine, and significant healthcare spending in the region. The United States represents the largest market, driven by the presence of leading regenerative medicine companies, extensive clinical research and development activities, and high patient awareness and acceptance of PRP therapies. Healthcare professionals in North America have embraced PRP as a standard therapeutic option across multiple specialties.

Europe represents the second-largest market for plasma therapy, driven by strong healthcare systems, increasing adoption of regenerative medicine approaches, and growing clinical evidence supporting PRP efficacy. Countries including Germany, France, and the United Kingdom are at the forefront of PRP therapy adoption and standardization efforts. The region's emphasis on evidence-based medicine and regulatory compliance is supporting market growth and clinical credibility.

Asia-Pacific is projected to witness the fastest growth during the forecast period. This accelerated growth is fueled by advancing healthcare infrastructure, increasing medical tourism, rising healthcare expenditure, and growing awareness of PRP therapies among healthcare professionals and patients. Countries including China, India, Japan, and South Korea are experiencing rapid expansion of plasma therapy markets. The combination of improving healthcare systems, growing disposable incomes, and increasing sports participation is driving substantial demand for regenerative medicine solutions. Latin America and the Middle East & Africa represent emerging market opportunities with growing healthcare investments and increasing adoption of advanced therapeutic approaches.

Key Players

The key players operating in the global plasma therapy market include established medical device manufacturers with strong distribution networks and specialized regenerative medicine companies focused on PRP technology development. The competitive landscape features a diverse range of manufacturers producing PRP preparation systems, centrifuges, and related medical devices. These companies compete based on the quality and consistency of their PRP preparation systems, technological innovation, clinical evidence supporting their products, therapeutic area expertise, and ability to provide comprehensive solutions that meet evolving healthcare provider needs. Market consolidation has characterized the industry, with larger players acquiring specialized PRP technology companies to expand their regenerative medicine portfolios and enhance technological capabilities.

Key Questions Answered in the Report-

  • What is the current revenue generated by the plasma therapy market globally?
  • At what rate is the global plasma therapy market demand projected to grow for the next 7-10 years?
  • What are the historical market sizes and growth rates of the global plasma therapy market?
  • What are the major factors impacting the growth of this market at the regional and country levels? What are the major opportunities for existing players and new entrants in the market?
  • Which segments in terms of type, application, and end user are expected to create major traction for the service providers in this market?
  • What are the key geographical trends in this market? Which regions/countries are expected to offer significant growth opportunities for the companies operating in the global plasma therapy market?
  • Who are the major players in the global plasma therapy market? What are their specific service offerings in this market?
  • What are the recent strategic developments in the global plasma therapy market? What are the impacts of these strategic developments on the market?

Scope of the Report:

Plasma Therapy Market Assessment -- by Type

  • Pure Platelet-rich Plasma (PRP)
  • Leukocyte-rich PRP (L-PRP)
  • Platelet-rich Fibrin (PRF)
  • Leukocyte and Platelet-rich Fibrin (L-PRF)

Plasma Therapy Market Assessment -- by Application

  • Orthopedics and Traumatology
  • Dermatology and Cosmetology
  • Rheumatology
  • Ophthalmology
  • Stomatology and Dental Surgery
  • Other Applications

Plasma Therapy Market Assessment -- by End User

  • Hospitals and Clinics
  • Research Institutes
  • Other End Users

Plasma Therapy Market Assessment -- by Geography

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Rest of Asia-Pacific
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • South Africa
  • Rest of Middle East & Africa

TABLE OF CONTENTS

1. Introduction

  • 1.1. Market Definition
  • 1.2. Market Ecosystem
  • 1.3. Currency
  • 1.4. Key Stakeholders

2. Research Methodology

  • 2.1. Research Process
  • 2.2. Data Collection & Validation
    • 2.2.1. Secondary Research
    • 2.2.2. Primary Research
  • 2.3. Market Assessment
    • 2.3.1. Market Size Estimation
    • 2.3.2. Bottom-Up Approach
    • 2.3.3. Top-Down Approach
    • 2.3.4. Growth Forecast
  • 2.4. Market Share Analysis
  • 2.5. Assumptions for this Study
  • 2.6. Limitations for the Study

3. Executive Summary

4. Market Insights

  • 4.1. Drivers
    • 4.1.1. Advantages Offered by PRP Treatment
    • 4.1.2. Increasing Awareness Toward PRP Therapies
    • 4.1.3. Rising Prevalence of Musculoskeletal and Sports Injuries
    • 4.1.4. Growing Number of Cosmetic Procedures Worldwide
  • 4.2. Restraints
    • 4.2.1. Availability of Alternatives for PRP Treatment
    • 4.2.2. Side-Effects Associated with the Use of PRP
  • 4.3. Opportunities
    • 4.3.1. Increasing Applications of PRP Treatments
    • 4.3.2. Advancing Healthcare in Emerging Economies
  • 4.4. Challenges
    • 4.4.1. Stringent Regulatory Framework for the Use of PRP
  • 4.5. Porter's Five Forces Analysis
    • 4.5.1. Bargaining Power of Suppliers
    • 4.5.2. Bargaining Power of Buyers
    • 4.5.3. Threat of Substitutes
    • 4.5.4. Threat of New Entrants
    • 4.5.5. Competitive Rivalry

5. PRP Qualification Criteria

6. Plasma Therapy Market Trends

7. Platelet Rich Plasma Therapy Market, by Type

  • 7.1. Introduction
  • 7.2. Pure Platelet-rich Plasma
  • 7.3. Leukocyte-rich PRP
  • 7.4. Pure Platelet Rich Fibrin
  • 7.5. Leukocyte and Platelet Rich Fibrin (L-PRF)

8. Platelet Rich Plasma Therapy Market, by Application

  • 8.1. Introduction
  • 8.2. Orthopedics and Traumatology
  • 8.3. Rheumatology
  • 8.4. Dermatology and Cosmetology
  • 8.5. Ophthalmology
  • 8.6. Stomatology and Odontology
  • 8.7. Other Applications

9. Platelet Rich Plasma Therapy Market, by End User

  • 9.1. Introduction
  • 9.2. Hospitals and Clinics
  • 9.3. Research Institutes

10. Platelet Rich Plasma Therapy Market, by Geography

  • 10.1. Introduction
  • 10.2. North America
    • 10.2.1. U.S.
    • 10.2.2. Canada
  • 10.3. Europe
    • 10.3.1. Germany
    • 10.3.2. France
    • 10.3.3. U.K.
    • 10.3.4. Italy
    • 10.3.5. Spain
    • 10.3.6. Rest of Europe
  • 10.4. Asia-Pacific
    • 10.4.1. Japan
    • 10.4.2. China
    • 10.4.3. India
    • 10.4.4. Rest of Asia-Pacific
  • 10.5. Latin America
    • 10.5.1. Brazil
    • 10.5.2. Mexico
    • 10.5.3. Argentina
    • 10.5.4. Rest of Latin America
  • 10.6. Middle East & Africa

11. Competitive Landscape

  • 11.1. Introduction
  • 11.2. Key Growth Strategies
  • 11.3. Market Share Analysis
  • 11.4. Key Players SWOT Analysis
  • 11.5. Funding and Grants Assessment

12. Company Profiles

  • 12.1. Arthrex, Inc.
  • 12.2. DePuy Synthes Inc.
  • 12.3. Stryker Corporation
  • 12.4. Zimmer Biomet Holdings, Inc.
  • 12.5. Terumo Corporation
  • 12.6. Regen Lab SA
  • 12.7. EmCyte Corporation
  • 12.8. Exactech Inc.
  • 12.9. Global Stem Cells Group, Inc.
  • 12.10. Celling Biosciences, Inc.
  • 12.11. Dr PRP USA LLC
  • 12.12. Juventix Regenerative Medical LLC
  • 12.13. Others

13. Appendix

  • 13.1. Questionnaire
  • 13.2. Available Customization